3 Recruiting Fallopian Tube Carcinoma Phase 2 Clinical Trials

Active phase 2 studies for fallopian tube carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.

All Fallopian Tube Carcinoma studies

Phase 2 Studies for Fallopian Tube Carcinoma

🔵 Active, Not Recruiting Phase1 / Phase2

Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

📍 Cedars-Sinai Medical Center — Los Angeles, California

View Study & Checklist ➔

🟢 Recruiting Phase2

IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2

Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer

📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona

View Study & Checklist ➔